Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101709-4 Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations) Find ^Patient 1Mo Ord PCL-5   ACTIVE Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations) [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101709-4   PCL-5     Observation       0       Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations)? N   1 month; 1 month (30 days); 30 days; EXT; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
10171-7 Symptoms & diseases Hx Eyes Pt Nar     ACTIVE History of Eyes disorders Narrative   NAM DefinitionDescription                   H&P.HX   10171-7                 0 Hx of Eyes disorders           H+P; H+P.HX; History; Narrative; Ophthalmologic; P prime; Point in time; Random; Report; Sx; Symp + dis; Vision; Visual 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101710-2 Trouble remembering important parts of the stressful experience Find ^Patient 1Mo Ord PCL-5   ACTIVE Trouble remembering important parts of the stressful experience [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101710-2   PCL-5     Observation       0       Trouble remembering important parts of the stressful experience? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101711-0 Loss of interest in activities that you used to enjoy Find ^Patient 1Mo Ord PCL-5   ACTIVE Loss of interest in activities that you used to enjoy [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101711-0   PCL-5     Observation       0       Loss of interest in activities that you used to enjoy? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101712-8 Feeling distant or cut off from other people Find ^Patient 1Mo Ord PCL-5   ACTIVE Feeling distant or cut off from other people [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101712-8   PCL-5     Observation       0       Feeling distant or cut off from other people? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101713-6 Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you) Find ^Patient 1Mo Ord PCL-5   ACTIVE Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you) [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101713-6   PCL-5     Observation       0       Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you)? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Pos; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101714-4 Irritable behavior, angry outbursts, or acting aggressively Find ^Patient 1Mo Ord PCL-5   ACTIVE Irritable behavior, angry outbursts, or acting aggressively [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101714-4   PCL-5     Observation       0       Irritable behavior, angry outbursts, or acting aggressively? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101715-1 Being superalert or watchful or on guard Find ^Patient 1Mo Ord PCL-5   ACTIVE Being superalert or watchful or on guard [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101715-1   PCL-5     Observation       0       Being superalert or watchful or on guard? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101716-9 Feeling jumpy or easily startled Find ^Patient 1Mo Ord PCL-5   ACTIVE Feeling jumpy or easily startled [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101716-9   PCL-5     Observation       0       Feeling jumpy or easily startled? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101717-7 Having difficulty concentrating Find ^Patient 1Mo Ord PCL-5   ACTIVE Having difficulty concentrating [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101717-7   PCL-5     Observation       0       Having difficulty concentrating? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101718-5 Trouble falling or staying asleep Find ^Patient 1Mo Ord PCL-5   ACTIVE Trouble falling or staying asleep [PCL-5]   NAM DefinitionDescription                   SURVEY.MTLHLTH   101718-5   PCL-5     Observation       0       Trouble falling or staying asleep? N   1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH 2.77 2.75                       0
101719-3 Nickel Ab.IgE ACnc Ser Pt Qn     ACTIVE Nickel IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     [IU]/mL             ALLERGY   101719-3         Both       0 Nickel IgE Qn       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; NI; Ni IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.77 2.75               [IU]/mL       0
10172-5 Symptoms & diseases Hx Hematologic system Pt Nar     ACTIVE History of Hematologic system disorders Narrative   NAM DefinitionDescription                   H&P.HX   10172-5                 0 Hx of Hematologic disorders           H+P; H+P.HX; Hemato; History; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101720-1 Disability status Imp ^Patient Pt Nom     ACTIVE Disability status   ADD DefinitionDescription                   HL7.CCDA   101720-1         Observation       0 Disability status       N   HL7CCDA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random 2.75 2.75                       0
101721-9 SARS coronavirus 2 RNA - Respiratory Pt - Probe.amp.tar   DEPRECATED Deprecated SARS-CoV-2 (COVID-19) in Respiratory specimen by NAA with probe detection   DEL DefinitionDescription                   MICRO   101721-9   Probe.amp.tar     Order       0 Deprecated SARS-CoV-2 Resp NAA+probe       N   2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus 2.76 2.75   Panel   AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101724-3 Certolizumab Ab MCnc Ser/Plas Pt Qn SPR   ACTIVE Certolizumab Ab [Mass/volume] in Serum or Plasma by SPR   ADD DefinitionDescription     ng/mL             DRUG/TOX   101724-3   SPR     Observation       0 Certolizumab Ab SerPl SPR-mCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CimziaÃ?®; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surface plasmon resonance spectroscopy 2.75 2.75               ng/mL       0
101727-6 JC virus DNA LaCnc Urine Pt Qn Probe.amp.tar   ACTIVE JC virus DNA [log units/volume] (viral load) in Urine by NAA with probe detection   ADD DefinitionDescription     Log IU/mL             MICRO   101727-6   Probe.amp.tar     Both       0 JCPyV DNA Ur NAA+probe-Log IU       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load 2.75 2.75               {Log_IU}/mL       0
101729-2 JC virus DNA ACnc Plas Pt Qn Probe.amp.tar   ACTIVE JC virus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101729-2   Probe.amp.tar     Both       0 JCPyV DNA Plas NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               [IU]/mL       0
10173-3 Symptoms & diseases Hx Musculoskeletal system Pt Nar     ACTIVE History of Musculoskeletal system disorders Narrative   NAM DefinitionDescription                   H&P.HX   10173-3                 0 Hx of Musculoskeletal disorders           H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101731-8 JC virus DNA LaCnc Ser/Plas Pt Qn Probe.amp.tar   ACTIVE JC virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection   ADD DefinitionDescription     Log IU/mL             MICRO   101731-8   Probe.amp.tar     Both       0 JCPyV DNA SerPl NAA+probe-Log IU       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               {Log_IU}/mL       0
101732-6 JC virus DNA LaCnc CSF Pt Qn Probe.amp.tar   ACTIVE JC virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection   ADD DefinitionDescription     Log IU/mL             MICRO   101732-6   Probe.amp.tar     Both       0 JCPyV DNA CSF NAA+probe-Log IU       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               {Log_IU}/mL       0
101733-4 JC virus DNA ACnc Urine Pt Qn Probe.amp.tar   ACTIVE JC virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101733-4   Probe.amp.tar     Both       0 JCPyV DNA Ur NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load 2.75 2.75               [IU]/mL       0
101734-2 Sodium Urate crystals EngDiff Urine 24H Qn     ACTIVE Sodium Urate crystals [Energy Difference] in 24 hour Urine   NAM DefinitionDescription     Delta G (kJ/mol)             CHEM   101734-2         Both       0 Na Urate cry 24h EngDiff Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; Monosodium Urate; Na; Na Urate; Na Urate cry; Na+; NaU; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn 2.76 2.75               kJ/mol       0
101735-9 Urate crystals EngDiff Urine 24H Qn     ACTIVE Urate crystals [Energy Difference] in 24 hour Urine   NAM DefinitionDescription     kJ/mol             CHEM   101735-9         Both       0 Urate Cry 24h EngDiff Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn 2.76 2.75               kJ/mol       0
101736-7 Brushite crystals EngDiff Urine 24H Qn     ACTIVE Calcium hydrogen phosphate dihydrate (CHPD) in 24 hour Urine   NAM DefinitionDescription     kJ/mol             CHEM   101736-7         Both       0 Ca H2 Phos dihyd (CHPD) 24h Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; QNT; Quan; Quant; Quantitative; UA; UR; Urn 2.76 2.75               kJ/mol       0
104,672 results found